VYNE Therapeutics Inc. — All Filings
608 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
4/A
424B2
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0001209191-18-005852 | Jan 29, 2018 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-18-005841 | Jan 29, 2018 | Jan 25, 2018 |
| 4 | FORM 4 SUBMISSION | 0001209191-18-005831 | Jan 29, 2018 | Jan 25, 2018 |
| 4 | FORM 4 SUBMISSION | 0001209191-18-005829 | Jan 29, 2018 | Jan 25, 2018 |
| 4 | FORM 4 SUBMISSION | 0001209191-18-005827 | Jan 29, 2018 | Jan 25, 2018 |
| S-8 | S-8 | 0001628280-18-000664 | Jan 29, 2018 | — |
| 8-K | 8-K | 0001628280-18-000648 | Jan 29, 2018 | Jan 26, 2018 |
| 424B4 | 424B4 | 0001628280-18-000611 | Jan 26, 2018 | — |
| CT ORDER | — | 9999999997-18-000502 | Jan 26, 2018 | — |
| EFFECT | — | 9999999995-18-000207 | Jan 24, 2018 | — |
| S-1MEF | S-1MEF | 0001628280-18-000564 | Jan 24, 2018 | — |
| 3 | PRIMARY DOCUMENT | 0000315066-18-000081 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005258 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005252 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005250 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005246 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005241 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005239 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005237 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005235 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005233 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005231 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005227 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005225 | Jan 24, 2018 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-18-005223 | Jan 24, 2018 | — |
| S-1/A | S-1/A | 0001628280-18-000542 | Jan 23, 2018 | — |
| CORRESP | — | 0001628280-18-000538 | Jan 22, 2018 | — |
| CORRESP | — | 0001628280-18-000537 | Jan 22, 2018 | — |
| CORRESP | — | 0001628280-18-000532 | Jan 22, 2018 | — |
| CORRESP | — | 0001628280-18-000523 | Jan 22, 2018 | — |
| CORRESP | — | 0001628280-18-000511 | Jan 19, 2018 | — |
| CORRESP | — | 0001628280-18-000510 | Jan 19, 2018 | — |
| CERT | — | 9999999997-18-000431 | Jan 19, 2018 | — |
| 8-A12B | 8-A12B | 0001628280-18-000505 | Jan 19, 2018 | — |
| CORRESP | — | 0001628280-18-000469 | Jan 19, 2018 | — |
| S-1/A | S-1/A | 0001628280-18-000456 | Jan 18, 2018 | — |
| CORRESP | — | 0001628280-18-000454 | Jan 18, 2018 | — |
| UPLOAD | — | 0000000000-18-001607 | Jan 17, 2018 | — |
| S-1/A | S-1/A | 0001628280-18-000299 | Jan 12, 2018 | — |
| CORRESP | — | 0001628280-18-000193 | Jan 5, 2018 | — |
| CORRESP | — | 0001628280-18-000141 | Jan 4, 2018 | — |
| S-1 | S-1 | 0001628280-17-012730 | Dec 28, 2017 | — |
| CORRESP | — | 0001628280-17-012728 | Dec 28, 2017 | — |
| UPLOAD | — | 0000000000-17-043683 | Dec 14, 2017 | — |
| DRS/A | — | 0001566044-17-000018 | Dec 5, 2017 | — |
| DRSLTR | — | 0001566044-17-000017 | Dec 4, 2017 | — |
| UPLOAD | — | 0000000000-17-041650 | Nov 28, 2017 | — |
| DRS | — | 0001566044-17-000010 | Oct 30, 2017 | — |
| DRSLTR | — | 0001566044-17-000009 | Oct 30, 2017 | — |
| D | — | 0001566044-17-000002 | Jul 28, 2017 | — |